FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029952357> ?p ?o ?g. }

• W2029952357 endingPage "256S" @default.
• W2029952357 startingPage "245S" @default.
• W2029952357 abstract "Although thrombolytic agents have been available for over 10 years and have demonstrated safety and efficacy in an increasing number of clinical conditions involving thrombotic phenomena, their general acceptance as first-line therapeutic agents in medical management has been slow. Much of the reluctance to use these drugs is based on their associated incidence of hemorrhagic complications, which is several-fold greater than with use of conventional anticoagulants. With the introduction of second-generation thrombolytic agents, made possible through successes in recombinant DNA technology and chemical modifications of previously available compounds, increased fibrin specificity has been achieved and has been translated into increased clinical efficacy and safety. These results will likely improve as innovative regimens using dose modifications or multiple agents with combined synergy are developed. An appreciation of basic coagulation and the pharmacology of anticoagulants and thrombolytic agents is necessary to maximize the benefits of currently available medications, to develop new treatment strategies, and to minimize potential hemorrhagic complications. Although thrombolytic agents have been available for over 10 years and have demonstrated safety and efficacy in an increasing number of clinical conditions involving thrombotic phenomena, their general acceptance as first-line therapeutic agents in medical management has been slow. Much of the reluctance to use these drugs is based on their associated incidence of hemorrhagic complications, which is several-fold greater than with use of conventional anticoagulants. With the introduction of second-generation thrombolytic agents, made possible through successes in recombinant DNA technology and chemical modifications of previously available compounds, increased fibrin specificity has been achieved and has been translated into increased clinical efficacy and safety. These results will likely improve as innovative regimens using dose modifications or multiple agents with combined synergy are developed. An appreciation of basic coagulation and the pharmacology of anticoagulants and thrombolytic agents is necessary to maximize the benefits of currently available medications, to develop new treatment strategies, and to minimize potential hemorrhagic complications." @default.
• W2029952357 created "2016-06-24" @default.
• W2029952357 creator A5038396248 @default.
• W2029952357 date "1989-05-01" @default.
• W2029952357 modified "2023-10-13" @default.
• W2029952357 title "Anticoagulation and Thrombolytic Therapy" @default.
• W2029952357 cites W1537851214 @default.
• W2029952357 cites W1550499229 @default.
• W2029952357 cites W1590554910 @default.
• W2029952357 cites W1947925671 @default.
• W2029952357 cites W1964537647 @default.
• W2029952357 cites W1967550469 @default.
• W2029952357 cites W1968710253 @default.
• W2029952357 cites W1969930542 @default.
• W2029952357 cites W1975871166 @default.
• W2029952357 cites W1979776304 @default.
• W2029952357 cites W1980123039 @default.
• W2029952357 cites W1986774920 @default.
• W2029952357 cites W1987232068 @default.
• W2029952357 cites W1994207065 @default.
• W2029952357 cites W1999674437 @default.
• W2029952357 cites W2001124978 @default.
• W2029952357 cites W2001563266 @default.
• W2029952357 cites W2001729311 @default.
• W2029952357 cites W2017729041 @default.
• W2029952357 cites W2017755964 @default.
• W2029952357 cites W2020475451 @default.
• W2029952357 cites W2020528791 @default.
• W2029952357 cites W2024500935 @default.
• W2029952357 cites W2025237854 @default.
• W2029952357 cites W2026021924 @default.
• W2029952357 cites W2031822551 @default.
• W2029952357 cites W2033354476 @default.
• W2029952357 cites W2035822703 @default.
• W2029952357 cites W2040675937 @default.
• W2029952357 cites W2046008595 @default.
• W2029952357 cites W2046979478 @default.
• W2029952357 cites W2049966994 @default.
• W2029952357 cites W2050021936 @default.
• W2029952357 cites W2053557642 @default.
• W2029952357 cites W2076315269 @default.
• W2029952357 cites W2077897140 @default.
• W2029952357 cites W2081963113 @default.
• W2029952357 cites W2085445739 @default.
• W2029952357 cites W2085869089 @default.
• W2029952357 cites W2086669019 @default.
• W2029952357 cites W2088753602 @default.
• W2029952357 cites W2112969867 @default.
• W2029952357 cites W2125389594 @default.
• W2029952357 cites W2132598197 @default.
• W2029952357 cites W2135189810 @default.
• W2029952357 cites W2141776787 @default.
• W2029952357 cites W2160443953 @default.
• W2029952357 cites W2162637702 @default.
• W2029952357 cites W2214576528 @default.
• W2029952357 cites W2314358062 @default.
• W2029952357 cites W2316102942 @default.
• W2029952357 cites W2319834083 @default.
• W2029952357 cites W2327059767 @default.
• W2029952357 cites W2328440105 @default.
• W2029952357 cites W2328870579 @default.
• W2029952357 cites W2336672206 @default.
• W2029952357 cites W2400531896 @default.
• W2029952357 cites W2401328430 @default.
• W2029952357 cites W2410439845 @default.
• W2029952357 cites W2413662286 @default.
• W2029952357 cites W2415007657 @default.
• W2029952357 cites W2417963531 @default.
• W2029952357 cites W2419999215 @default.
• W2029952357 cites W2433010030 @default.
• W2029952357 cites W2483011995 @default.
• W2029952357 cites W4242263299 @default.
• W2029952357 cites W4254009866 @default.
• W2029952357 doi "https://doi.org/10.1378/chest.95.5.245s" @default.
• W2029952357 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2651044" @default.
• W2029952357 hasPublicationYear "1989" @default.
• W2029952357 type Work @default.
• W2029952357 sameAs 2029952357 @default.
• W2029952357 citedByCount "4" @default.
• W2029952357 countsByYear W20299523572014 @default.
• W2029952357 countsByYear W20299523572015 @default.
• W2029952357 crossrefType "journal-article" @default.
• W2029952357 hasAuthorship W2029952357A5038396248 @default.
• W2029952357 hasConcept C126322002 @default.
• W2029952357 hasConcept C177713679 @default.
• W2029952357 hasConcept C203014093 @default.
• W2029952357 hasConcept C2776572282 @default.
• W2029952357 hasConcept C2909817843 @default.
• W2029952357 hasConcept C54173615 @default.
• W2029952357 hasConcept C71924100 @default.
• W2029952357 hasConceptScore W2029952357C126322002 @default.
• W2029952357 hasConceptScore W2029952357C177713679 @default.
• W2029952357 hasConceptScore W2029952357C203014093 @default.
• W2029952357 hasConceptScore W2029952357C2776572282 @default.
• W2029952357 hasConceptScore W2029952357C2909817843 @default.
• W2029952357 hasConceptScore W2029952357C54173615 @default.
• W2029952357 hasConceptScore W2029952357C71924100 @default.
• W2029952357 hasIssue "5" @default.

• next